Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

CC Mok, KY Ying, CW Yim, YP Siu, KH Tong… - Annals of the …, 2016 - ard.bmj.com
Objective To compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) for
the initial therapy of lupus nephritis (LN). Study design This is an open randomised …

Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial

CC Mok, KY Ying, CS Lau, CW Yim, WL Ng… - American journal of …, 2004 - Elsevier
Background: The aim of this study was to report the outcome of pure membranous lupus
nephropathy treated with prednisone and azathioprine (AZA). Methods: Consecutive patients …

Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis—a randomized trial

…, RJ Li, KL Lee, YY Leung, KY Ying, CW Yim… - The Journal of …, 2012 - jrheum.org
Objective. To determine the efficacy of methotrexate (MTX) with infliximab (IFX) compared
with MTX alone in the prevention of atherosclerosis and arterial stiffness in patients with early …

[HTML][HTML] Role of interleukin 6 inhibitors in the management of rheumatoid arthritis

RML Yip, CW Yim - JCR: Journal of Clinical Rheumatology, 2021 - journals.lww.com
Rheumatoid arthritis (RA) is a multisystem disease that affects the joints and various organs,
resulting in compromised quality of life and increased mortality. A wide spectrum of …

IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study

…, RJ Li, KL Lee, YY Leung, KY Ying, CW Yim… - Seminars in arthritis and …, 2015 - Elsevier
Objectives To study the association between the baseline IL-33 and soluble ST2 (sST2)
levels with disease remission and progression of carotid atherosclerosis in early rheumatoid …

Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry

CC Mok, H So, CW Yim, CH To, WN Lao… - …, 2024 - academic.oup.com
Objectives To compare the incidence of major adverse cardiovascular events (MACEs),
cancer and infective complications in RA patients using Janus kinase (JAKis) and TNF (TNFis) …

DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study

…, EK Li, P Wong, J Lee, RML Yip, CW Yim… - Annals of the …, 2020 - ard.bmj.com
Objective To examine whether Disease Activity in Psoriatic Arthritis (DAPSA) reflecting the
inflammatory component of psoriatic arthritis (PsA) can predict cardiovascular (CV) events …

Hyperuricemia in Asian psoriatic arthritis patients

TL Lai, CW Yim, PY Wong, MC Leung… - International Journal of …, 2018 - Wiley Online Library
Aim It is generally accepted that hyperuricemia is commonly associated with psoriatic arthritis
(PsA). However, variations in ethnicity, diet and habitat may contribute to differences in …

Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study

…, TT Cheung, VW Lao, HT Pang, CH To, CW Yim… - …, 2023 - academic.oup.com
Objectives This study explored whether the excess cardiovascular (CV) disease (CVD) risk
in RA could be ameliorated by suppression of inflammation using a treat-to-target (T2T) …

Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis—a prospective study

…, RJ Li, KL Lee, YY Leung, KY Ying, CW Yim… - Seminars in Arthritis and …, 2013 - Elsevier
OBJECTIVE: We assessed whether a serum soluble receptor for advanced glycation end
product (sRAGE) levels were associated with a progression of carotid atherosclerosis and …